Page last updated: 2024-11-06

mitomycin and B-Cell Chronic Lymphocytic Leukemia

mitomycin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 4 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"We studied the ability of chronic lymphocytic leukemia (CLL) B cells to stimulate proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in a mixed lymphocyte tumor-cell culture (MLTC)."1.28B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes. ( Cesano, A; Foa, R; Giovarelli, M; Lusso, P; Massaia, M; Matera, L; Piazza, A; Santoli, D; Veglia, F, 1989)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmutz, JL1
Trechot, P1
Bramson, J1
McQuillan, A1
Aubin, R1
Alaoui-Jamali, M1
Batist, G1
Christodoulopoulos, G1
Panasci, LC1
Briggs, PG1
Kraft, N1
Atkins, RC1
Matera, L1
Foa, R1
Massaia, M1
Giovarelli, M1
Veglia, F1
Cesano, A1
Lusso, P1
Piazza, A1
Santoli, D1

Other Studies

4 other studies available for mitomycin and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
[Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide].
    Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:3

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot

2013
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Mutation research, 1995, Volume: 336, Issue:3

    Topics: B-Lymphocytes; Chlorambucil; Cisplatin; Cross-Linking Reagents; DNA Adducts; DNA Damage; DNA Repair;

1995
T-lymphocyte response to cytokines in B-chronic lymphocytic leukemia.
    Leukemia research, 1991, Volume: 15, Issue:9

    Topics: Cytokines; Humans; In Vitro Techniques; Interleukin-1; Interleukin-2; Leukemia, Lymphocytic, Chronic

1991
B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes.
    Journal of clinical immunology, 1989, Volume: 9, Issue:4

    Topics: B-Lymphocytes; Cytotoxicity, Immunologic; Gamma Rays; HLA-D Antigens; Humans; Interferons; Interleuk

1989